Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes
- PMID: 24994788
- PMCID: PMC4134420
- DOI: 10.1177/1479164114539713
Haptoglobin genotype and cerebrovascular disease incidence in type 1 diabetes
Abstract
Objective: We prospectively evaluated the haptoglobin (Hp)-stroke association in type 1 diabetes and hypothesized that despite increasing the risk of coronary artery disease, the presence of the Hp 2 allele would be associated with a lower incidence of stroke.
Methods: Participants from the Epidemiology of Diabetes Complications study without prevalent stroke and Hp available were evaluated (n = 607; mean age 27.6 years and duration 19.3 years).
Results: During 22 years of follow-up, stroke incidence did not differ by Hp genotype (p = 0.49). Restricting analyses to those diagnosed with diabetes ≥1965 (13% mortality vs 40% in the <1965 cohort) to diminish potential survival bias, the adjusted hazard ratio (HR) for Hp 1-1 was 3.08 (95% confidence interval (CI) = 0.81-11.77, p = 0.10). Further stratifying by hypertension prevalence, an increased stroke incidence was observed with Hp 1-1 only in those with hypertension (HR = 7.03, 95% CI = 1.42-34.89, p = 0.02).
Conclusion: Despite the protective effect against vascular diabetes complications, a borderline increased risk of stroke was observed with Hp 1-1 in type 1 diabetes. This mixed Hp effect on cardiovascular risk by outcome studied merits further investigation and cautions against the universal application of preventive therapies across all Hp genotypes.
Keywords: Type 1 diabetes; coronary artery disease; haptoglobin genotype; hypertension; stroke.
© The Author(s) 2014.
Figures


Similar articles
-
The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.Eur J Prev Cardiol. 2018 Sep;25(14):1502-1519. doi: 10.1177/2047487318776829. Epub 2018 May 25. Eur J Prev Cardiol. 2018. PMID: 29799294 Review.
-
The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes.J Diabetes Complications. 2016 Mar;30(2):221-6. doi: 10.1016/j.jdiacomp.2015.11.011. Epub 2015 Nov 14. J Diabetes Complications. 2016. PMID: 26684170 Free PMC article.
-
Haptoglobin genotype: a determinant of cardiovascular complication risk in type 1 diabetes.Diabetes. 2008 Jun;57(6):1702-6. doi: 10.2337/db08-0095. Epub 2008 Mar 10. Diabetes. 2008. PMID: 18332093
-
Haptoglobin genotype predicts development of coronary artery calcification in a prospective cohort of patients with type 1 diabetes.Cardiovasc Diabetol. 2011 Nov 20;10:99. doi: 10.1186/1475-2840-10-99. Cardiovasc Diabetol. 2011. PMID: 22098782 Free PMC article.
-
Haptoglobin genotype and its role in diabetic cardiovascular disease.J Cardiovasc Transl Res. 2012 Aug;5(4):423-35. doi: 10.1007/s12265-012-9361-z. Epub 2012 Mar 24. J Cardiovasc Transl Res. 2012. PMID: 22447230 Free PMC article. Review.
Cited by
-
Association of the Haptoglobin Gene Polymorphism With Cognitive Function and Decline in Elderly African American Adults With Type 2 Diabetes: Findings From the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Study.JAMA Netw Open. 2018 Nov 2;1(7):e184458. doi: 10.1001/jamanetworkopen.2018.4458. JAMA Netw Open. 2018. PMID: 30646354 Free PMC article.
-
Meta-genome-wide association studies identify a locus on chromosome 1 and multiple variants in the MHC region for serum C-peptide in type 1 diabetes.Diabetologia. 2018 May;61(5):1098-1111. doi: 10.1007/s00125-018-4555-9. Epub 2018 Feb 5. Diabetologia. 2018. PMID: 29404672 Free PMC article.
-
Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementation.Pharmgenomics Pers Med. 2018 Apr 23;11:71-82. doi: 10.2147/PGPM.S159454. eCollection 2018. Pharmgenomics Pers Med. 2018. PMID: 29731659 Free PMC article.
-
New and emerging biomarkers in cardiovascular disease.Curr Diab Rep. 2015 Nov;15(11):88. doi: 10.1007/s11892-015-0661-y. Curr Diab Rep. 2015. PMID: 26370699 Review.
-
Role of Haptoglobin in Health and Disease: A Focus on Diabetes.Clin Diabetes. 2016 Jul;34(3):148-57. doi: 10.2337/diaclin.34.3.148. Clin Diabetes. 2016. PMID: 27621532 Free PMC article.
References
-
- Fuller JH, Stevens LK, Wang SL. Risk factors for cardiovascular mortality and morbidity: the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia. 2001;44(Suppl 2):S54–S64. - PubMed
-
- Laing SP, Swerdlow AJ, Carpenter LM, et al. Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetes. Stroke. 2003;34:418–421. - PubMed
-
- Davis TM, Bruce DG, Davis WA. Predictors of first stroke in Type 1 diabetes: The Fremantle Diabetes Study. Diabet Med. 2005;22:551–553. - PubMed
-
- Staals J, Pieters BMA, Knottnerus ILH, Rouhl RPW, van Oostenbrugge RJ, Delanghe JR, Tervaert JW, Lodder J. Haptoglobin Polymorphism and Lacunar Stroke. Curr Neurovasc Res. 2008;5:153–158. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous